Dr. Gil Kliman and Tom Frinzi Appointed to STAAR Surgical Board of Directors
June 01 2020 - 7:00AM
Business Wire
STAAR Surgical Company (NASDAQ: STAA), a leading developer,
manufacturer and marketer of implantable lenses and companion
delivery systems for the eye, today announced the appointment of
Gilbert H. Kliman, M.D., Managing Partner, InterWest Partners and
Thomas G. Frinzi, former Worldwide President, Surgical, Johnson
& Johnson Vision, to its Board of Directors, effective June 1,
2020. The appointment of Messrs. Kliman and Frinzi brings the total
number of members on STAAR's Board to six.
"The addition of Dr. Gil Kliman and Tom Frinzi to the STAAR
Surgical Board of Directors adds extensive ophthalmology,
commercial and medical device expertise to STAAR," said Lou
Silverman, Chairman of the Board of STAAR Surgical. "Dr. Kliman is
an investment professional and former practicing ophthalmologist
who will bring a broad range of experiences and perspectives to
STAAR’s Board. Tom’s leadership track record in ophthalmology and
medical device spans more than 30 years and encompasses both large,
well-established companies and innovative start-ups. We believe Gil
and Tom’s familiarity with the opportunities and challenges faced
by growth-oriented ophthalmic companies will provide valuable
insight. On behalf of the entire Board, we look forward to Gil and
Tom’s contributions to STAAR’s future successes.”
In addition to Dr. Kliman and Mr. Frinzi, STAAR will nominate
its current directors, Stephen Farrell, Caren Mason, John Moore and
Louis Silverman for election to serve as directors at its 2020
Annual Meeting of Shareholders scheduled for July 30, 2020.
About Gil Kliman
Gil Kliman, M.D., 61, is a Managing Partner of InterWest
Partners, a venture capital firm where he has been a partner since
1996. Dr. Kliman is a board-certified ophthalmologist and completed
his residency at Wills Eye Hospital and a retina fellowship at
Massachusetts Eye and Ear Infirmary as a Heed Foundation fellow. He
holds a B.A. from Harvard University, an M.D. from the University
of Pennsylvania and an MBA from the Stanford Graduate School of
Business. Dr. Kliman has served on the board of directors of
Glaukos Corporation almost continuously since 2007, was a lead
investor and director of Avedro (acquired by Glaukos) and IntraLase
(acquired by AMO), and currently serves as a director for ORBIS
International and private healthcare companies.
About Tom Frinzi
Tom Frinzi, 64, served as Worldwide President, Surgical, Johnson
& Johnson Vision from February 2017 through December 2019. Mr.
Frinzi was Senior Vice President of Abbott Laboratories and
President of Abbott Medical Optics (AMO) from January 2016 through
February 2017 when Johnson & Johnson acquired AMO. Prior to
joining AMO, Mr. Frinzi held a number of leadership positions in
ophthalmology and medical device companies. He served as President
and CEO of WaveTec Vision from 2010 through 2014, when it was
acquired by Alcon. He has also held senior positions in commercial
operations, business development, and sales and marketing at Bausch
& Lomb Surgical, Refractec and Chiron Vision. Mr. Frinzi earned
a B.A. in political science from the University of Tampa.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 30 years, designs, develops, manufactures and markets
implantable lenses for the eye, with companion delivery systems.
These lenses are intended to provide visual freedom for patients,
lessening or eliminating the reliance on glasses or contact lenses.
All of these lenses are foldable, which permits the surgeon to
insert them through a small incision. STAAR’s lens used in
refractive surgery is called an Implantable Collamer® Lens or
“ICL,” which includes the EVO Visian ICL™ product line. More than
1,000,000 Visian® ICLs have been implanted to date and STAAR
markets these lenses in over 75 countries. To learn more about the
ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA,
the company operates manufacturing and packaging facilities in
Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more
information, please visit the Company’s website at
www.staar.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200601005152/en/
Investors & Media Brian Moore Vice President,
Investor, Media Relations and Corporate Development (626) 303-7902,
Ext. 3023 bmoore@staar.com
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Aug 2024 to Sep 2024
STAAR Surgical (NASDAQ:STAA)
Historical Stock Chart
From Sep 2023 to Sep 2024